ScholarLens Back to search
2019•Journal of the National Comprehensive Cancer NetworkRequires access

Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Sarah Bean, Kristin A. Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, David E. Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Jonathan Frederick, David K. Gaffney, Ernest Soyoung Han, Warner King Huh, John Robert Lurain, Andrea Mariani, David G. Mutch, Christa Irene Nagel, Larissa Nekhlyudov, Amanda N. Fader, Steven W. Remmenga, R. Kevin Reynolds, Rachel Sisodia, Todd D. Tillmanns, Stefanie M. Ueda, Emily Wyse, Nicole R. McMillian, Jillian L. Scavone

Open publisher page 147 citations

Abstract

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.

About this research paper

What this paper is about

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.

Why it matters

OpenAlex reports 147 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.

Key concepts: Gestational trophoblastic neoplasia, Medicine, Gestational trophoblastic disease, Trophoblastic Tumor, Placental site trophoblastic tumor, Molar pregnancy, Obstetrics, Gynecology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology — Research Paper | ScholarLens